Main Navigation

Mercia
  • Ventures
  • Debt
  • Private equity
  • Contact us
  • About us
  • Investment strategies
  • Investor area
    • PLC
    • EIS
    • VCT
  • Contact us

Audience

|

Change

  • Ventures
  • Debt
  • Private equity
  • Contact us
  • About us
    • About us
      • Our history
      • Our vision and values
      • University partnerships
    • Team
    • Careers
    • Portfolio
    • Sustainability
  • Strategies
    • Our investment strategy
      • Our funds
    • Strategic assets
    • Property development finance
    • EIS & VCT
  • For shareholders
    • Share price
    • Board of directors
    • Financial reports & presentations
    • Regulatory news
    • Corporate governance
    • AIM Rule 26
    • Organisational structure
    • Annual Report
    • VCT
      • Northern Venture Trust
      • Northern 2 VCT
      • Northern 3 VCT
  • Insights & Research
    • Hub
  • Ventures
  • Debt
  • Private equity
  • Contact us
  • About us
  • Investment strategies
  • Investor area
    • PLC
    • EIS
    • VCT
  • Contact us
  • About us
    • About us
      • Our history
      • Our vision and values
      • University partnerships
    • Team
    • Careers
    • Portfolio
    • Sustainability
  • Strategies
    • Our investment strategy
      • Our funds
    • Strategic assets
    • Property development finance
    • EIS & VCT
  • For shareholders
    • Share price
    • Board of directors
    • Financial reports & presentations
    • Regulatory news
    • Corporate governance
    • AIM Rule 26
    • Organisational structure
    • Annual Report
    • VCT
      • Northern Venture Trust
      • Northern 2 VCT
      • Northern 3 VCT
  • Insights & Research
    • Hub

Corporate

Corporate
Direct Investments | 14th December, 2016
New Life sciences & Bio-sciences Advisory Board appointed to accelerate growth of portfolio
Corporate | 9th December, 2016
Mercia expands its Midlands team with appointment of new Investment Director
Direct Investments | 27th September, 2016
New investment into innovative healthcare company, Medherant
Direct Investments | 2nd August, 2016
Zika protein developed by Mercia ‘Emerging Star’ used to generate unique tools for virus detection
Direct Investments | 28th July, 2016
Mercia appoints games industry veterans to new advisory board
Corporate | 20th June, 2016
Mercia secures four new university partnerships in the North and Scotland
Corporate | 9th May, 2016
First direct investment into new ’emerging star’ from the Enterprise Ventures Group portfolio
EV Growth Fund | 18th March, 2016
Mercia acquires Enterprise Ventures Group Limited
Direct Investments | 26th February, 2016
2016 – A year of growth as Mercia’s team strengthens
Direct Investments | 20th January, 2016
Science Warehouse announces strong half year results as it appoints new CTO
Loading...
Loading...

Disclaimer

Which of these options best describes you?

Please wait...
Accept

Disclaimers

Which of these options best describes you?

Please wait...
Accept

© 2025 Mercia Asset Management

  • Contact us
  • Privacy policy
  • Terms and conditions
  • Modern Slavery Statement
  • Diversity, Equity & Inclusion Policy
  • Sustainability

Mercia Asset Management PLC is registered in England and Wales: 09223445. Its subsidiaries, Mercia Fund Management Limited, Mercia Regional Ventures Limited, Mercia Business Loans Limited and Frontier Development Capital Limited are authorised and regulated by the Financial Conduct Authority.

Loading...
Loading...

Disclaimer

Which of these options best describes you?

Please wait...
Accept

Disclaimers

Which of these options best describes you?

Please wait...
Accept